Research Grants show all

NIH1

Patents show all

12Applications9Issued

SEC Filings show all

D1

SEC Form D Funding Events

DateOfferedSoldType
2011-02-22$4,002,000$999,987Equity, Other

Key Executives

  • Michael Bevilacqua
    Executive Officer, Director
  • Scott Hayashi
    Executive Officer
  • Michael Flesch
    Executive Officer, Director
  • Joseph Boystak
    Executive Officer, Director